Terms: = Leukemia AND PRF1, P14222, PFP, P1, MGC65093, HPLH2, FLH2, ENSG00000180644, 5551 AND Prognosis
19 results:
1. Pharmacological Inhibition of PIP4K2 Potentiates Venetoclax-Induced Apoptosis in Acute Myeloid leukemia.
Lima K; Carvalho MFL; Pereira-Martins DA; Nogueira FL; de Miranda LBL; Nascimento MCD; Cavaglieri RC; Schuringa JJ; Machado-Neto JA; Rego EM
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069220
[TBL] [Abstract] [Full Text] [Related]
2. Purification, crystallization, and X-ray diffraction analysis of myocyte enhancer factor 2D and DNA complex.
Chen Z; Wang Q; Zhang H; Ma X; Wu W; Cheng N; Zhang J; Zhou A; Li Y; Meng G
Protein Expr Purif; 2021 Mar; 179():105788. PubMed ID: 33221504
[TBL] [Abstract] [Full Text] [Related]
3. Perforin gene variation influences survival in childhood acute lymphoblastic leukemia.
Jaworowska A; Pastorczak A; Trelinska J; Wypyszczak K; Borowiec M; Fendler W; Sedek L; Szczepanski T; Ploski R; Młynarski W
Leuk Res; 2018 Feb; 65():29-33. PubMed ID: 29304394
[TBL] [Abstract] [Full Text] [Related]
4. Glutathione S transferase (GSTP 1, GSTM 1, and GSTT 1) gene polymorphisms in Egyptian patients with acute myeloid leukemia.
Nasr AS; Sami RM; Ibrahim NY; Darwish DO
Indian J Cancer; 2015; 52(4):490-5. PubMed ID: 26960454
[TBL] [Abstract] [Full Text] [Related]
5. FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas.
Brown PJ; Wong KK; Felce SL; Lyne L; Spearman H; Soilleux EJ; Pedersen LM; Møller MB; Green TM; Gascoyne DM; Banham AH
Leukemia; 2016 Mar; 30(3):605-16. PubMed ID: 26500140
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic and predictive significance of smudge cell percentage on routine blood smear in chronic lymphocytic leukemia.
Gogia A; Raina V; Gupta R; Gajendra S; Kumar L; Sharma A; Kumar R; Vishnubhatla S
Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):514-7. PubMed ID: 24656596
[TBL] [Abstract] [Full Text] [Related]
7. Therapeutic potential of MEK inhibition in acute myelogenous leukemia: rationale for "vertical" and "lateral" combination strategies.
Ricciardi MR; Scerpa MC; Bergamo P; Ciuffreda L; Petrucci MT; Chiaretti S; Tavolaro S; Mascolo MG; Abrams SL; Steelman LS; Tsao T; Marchetti A; Konopleva M; Del Bufalo D; Cognetti F; Foà R; Andreeff M; McCubrey JA; Tafuri A; Milella M
J Mol Med (Berl); 2012 Oct; 90(10):1133-44. PubMed ID: 22399013
[TBL] [Abstract] [Full Text] [Related]
8. Identification of trypsin-inhibitory site and structure determination of human SPINK2 serine proteinase inhibitor.
Chen T; Lee TR; Liang WG; Chang WS; Lyu PC
Proteins; 2009 Oct; 77(1):209-19. PubMed ID: 19422058
[TBL] [Abstract] [Full Text] [Related]
9. NUP98 is fused to HOXA9 in a variant complex t(7;11;13;17) in a patient with AML-M2.
Lahortiga I; Belloni E; Vázquez I; Agirre X; Larrayoz MJ; Vizmanos JL; Valgañón M; Zudaire I; Sáez B; Mateos MC; Di Fiore PP; Calasanz MJ; Odero MD
Cancer Genet Cytogenet; 2005 Mar; 157(2):151-6. PubMed ID: 15721637
[TBL] [Abstract] [Full Text] [Related]
10. Interphase fluorescence in situ hybridization assay for the detection of rearrangements of the EVI-1 locus in chromosome band 3q26 in myeloid malignancies.
Wieser R; Schreiner U; Rieder H; Pirc-Danoewinata H; Grüner H; Loncarevic IF; Fonatsch C
Haematologica; 2003 Jan; 88(1):25-30. PubMed ID: 12551823
[TBL] [Abstract] [Full Text] [Related]
11. Juxtamembrane mutant V560GKit is more sensitive to Imatinib (STI571) compared with wild-type c-kit whereas the kinase domain mutant D816VKit is resistant.
Frost MJ; Ferrao PT; Hughes TP; Ashman LK
Mol Cancer Ther; 2002 Oct; 1(12):1115-24. PubMed ID: 12481435
[TBL] [Abstract] [Full Text] [Related]
12. Post-induction residual disease in translocation t(12;21)-positive childhood ALL.
Seyfarth J; Madsen HO; Nyvold C; Ryder LP; Clausen N; Jonmundsson GK; Wesenberg F; Schmiegelow K
Med Pediatr Oncol; 2003 Feb; 40(2):82-7. PubMed ID: 12461790
[TBL] [Abstract] [Full Text] [Related]
13. Mapping of the breakpoints on the short arm of chromosome 17 in neoplasms with an i(17q).
Scheurlen WG; Schwabe GC; Seranski P; Joos S; Harbott J; Metzke S; Döhner H; Poustka A; Wilgenbus K; Haas OA
Genes Chromosomes Cancer; 1999 Jul; 25(3):230-40. PubMed ID: 10379869
[TBL] [Abstract] [Full Text] [Related]
14. Cytogenetic findings in acute biphenotypic leukaemia.
Carbonell F; Swansbury J; Min T; Matutes E; Farahat N; Buccheri V; Morilla R; Secker-Walker L; Catovsky D
Leukemia; 1996 Aug; 10(8):1283-7. PubMed ID: 8709632
[TBL] [Abstract] [Full Text] [Related]
15. The non-random dic(9;12) translocation in acute lymphoblastic leukemia is associated with B-progenitor phenotype and an excellent prognosis.
Mahmoud H; Carroll AJ; Behm F; Raimondi SC; Schuster J; Borowitz M; Land V; Pullen DJ; Vietti TJ; Crist W
Leukemia; 1992 Jul; 6(7):703-7. PubMed ID: 1625489
[TBL] [Abstract] [Full Text] [Related]
16. Cytogenetics of pre-B-cell acute lymphoblastic leukemia with emphasis on prognostic implications of the t(1;19).
Raimondi SC; Behm FG; Roberson PK; Williams DL; Pui CH; Crist WM; Look AT; Rivera GK
J Clin Oncol; 1990 Aug; 8(8):1380-8. PubMed ID: 2380759
[TBL] [Abstract] [Full Text] [Related]
17. Hypodiploidy is associated with a poor prognosis in childhood acute lymphoblastic leukemia.
Pui CH; Williams DL; Raimondi SC; Rivera GK; Look AT; Dodge RK; George SL; Behm FG; Crist WM; Murphy SB
Blood; 1987 Jul; 70(1):247-53. PubMed ID: 3474042
[TBL] [Abstract] [Full Text] [Related]
18. [Simultaneous determination of cellular DNA and proteins by cytofluorimetry. Application to acute leukemia in adults].
Ffrench M; Fiere D; Bryon PA; Cordier G; Viala JJ
Pathol Biol (Paris); 1984 Feb; 32(2):139-43. PubMed ID: 6366709
[TBL] [Abstract] [Full Text] [Related]
19. [Significance of PAS-positive myeloblastic leukemia].
Abbrederis K; Schmalzl F; Braunsteiner H
Blut; 1976 Aug; 33(2):103-8. PubMed ID: 61050
[TBL] [Abstract] [Full Text] [Related]
